TOP2A and cancer: Since transient inactivation of targets is of the outmost importance to predict cell response to pharmacological drugs and also uncover adjuvant treatments, our results point toward upregulation of mitotic exit as a putative target to synergistically promote cell death upon Top2 downregulation/mutation in cancer cells.